Gaiger A, Mannhalter C, Hinterberger W, Haas O, Marosi C, Kier P, Eichinger S, Funovic M, Lechner K
First Department of Medicine, University of Vienna Medical School, Austria.
Ann Hematol. 1991 Oct;63(4):227-8. doi: 10.1007/BF01703449.
Detection of host cells in peripheral blood and/or bone marrow (mixed chimerism) of patients who have undergone bone marrow transplantation (BMT) is possible using either immunological methods or cytogenetic or molecular genetic analysis. We shall report a new method for the detection of mixed chimerism, which makes use of the fact, that the von Willebrand factor (vWF) gene has a highly variable region-variable number of tandem repeats (VNTR)--within intron 40. vWF-VNTR amplification by the polymerase chain reaction (PCR) was performed as described by Peake et al. We have studied 185 peripheral blood and/or bone marrow samples of 26 patients. Median time after BMT was 14 months (range 1-83 months). Of the 11 patients who were studied sequentially during the first 100 days following BMT, mixed chimerism was detected in four, but only transiently. None of these patients has relapsed so far. Of 18 patients who were studied more than 100 days after BMT mixed chimerism was found in three; two of these patients have subsequently relapsed. The advantages of this new method are: (a) it is informative in a high percentage of patients; (b) it requires only small amounts (200 microliters) of peripheral blood; (c) reliable results can be obtained at leukocyte counts of even less than 50 per microliters. The clinical relevance and sensitivity of the method compared with established methods for detection of mixed chimerism remain to be determined.
利用免疫学方法或细胞遗传学及分子遗传学分析,可检测接受骨髓移植(BMT)患者外周血和/或骨髓中的宿主细胞(混合嵌合体)。我们将报告一种检测混合嵌合体的新方法,该方法利用了血管性血友病因子(vWF)基因在第40内含子中有一个高度可变区——串联重复可变数目(VNTR)这一事实。按照Peake等人所述方法,通过聚合酶链反应(PCR)进行vWF - VNTR扩增。我们研究了26例患者的185份外周血和/或骨髓样本。BMT后的中位时间为14个月(范围1 - 83个月)。在BMT后的前100天内对11例患者进行了连续研究,其中4例检测到混合嵌合体,但只是短暂出现。到目前为止,这些患者均未复发。在BMT后100天以上进行研究的18例患者中,有3例发现混合嵌合体;其中2例患者随后复发。这种新方法的优点是:(a)在高比例患者中具有信息价值;(b)仅需少量(200微升)外周血;(c)即使白细胞计数低于每微升50个也能获得可靠结果。与已确立的混合嵌合体检测方法相比,该方法的临床相关性和敏感性仍有待确定。